Reducing antimicrobial overuse through targeted therapy for patients with community-acquired pneumonia: a study protocol for a cluster-randomized factorial controlled trial (CARE-CAP)

[1] Musher DM(2014)Community-acquired pneumonia N Engl J Med 371 1619-1628

[2] Thorner AR(2015)Incidence, direct costs and duration of hospitalization of patients hospitalized with community acquired pneumonia: a nationwide retrospective claims database analysis Vaccine 33 3193-3199

[3] Rozenbaum MH(2017)Adults hospitalized with pneumonia in the United States: incidence, epidemiology, and mortality Clin Infect Dis 65 1806-1812

[4] Mangen MJ(2015)Community-acquired pneumonia requiring hospitalization among U.S. adults N Engl J Med 373 415-27

[5] Huijts SM(2013)Current management of patients hospitalized with community-acquired pneumonia across Europe: outcomes from REACH Respir Res 14 44-e67

[6] van der Werf TS(2019)Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American thoracic society and infectious diseases society of America Am J Respir Crit Care Med 200 e45-56

[7] Postma MJ(2014)Patterns of initial antibiotic therapy for community-acquired pneumonia in U.S. hospitals, 2000 to 2009 Am J Med Sci 347 347-1371

[8] Ramirez JA(2019)Broad-spectrum antibiotic use and poor outcomes in community-onset pneumonia: a cohort study Eur Respir J 54 1900057-944

[9] Wiemken TL(2015)Hospital resource utilization and patient outcomes associated with respiratory viral testing in hospitalized patients Emerg Infect Dis 21 1366-1434

[10] Peyrani P(2017)Multiplex respiratory virus testing for antimicrobial stewardship: a prospective assessment of antimicrobial use and clinical outcomes among hospitalized adults J Infect Dis 216 936-825

[1] Musher DM(2014)Community-acquired pneumonia N Engl J Med 371 1619-1628

[2] Thorner AR(2015)Incidence, direct costs and duration of hospitalization of patients hospitalized with community acquired pneumonia: a nationwide retrospective claims database analysis Vaccine 33 3193-3199

[3] Rozenbaum MH(2017)Adults hospitalized with pneumonia in the United States: incidence, epidemiology, and mortality Clin Infect Dis 65 1806-1812

[4] Mangen MJ(2015)Community-acquired pneumonia requiring hospitalization among U.S. adults N Engl J Med 373 415-27

[5] Huijts SM(2013)Current management of patients hospitalized with community-acquired pneumonia across Europe: outcomes from REACH Respir Res 14 44-e67

[6] van der Werf TS(2019)Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American thoracic society and infectious diseases society of America Am J Respir Crit Care Med 200 e45-56

[7] Postma MJ(2014)Patterns of initial antibiotic therapy for community-acquired pneumonia in U.S. hospitals, 2000 to 2009 Am J Med Sci 347 347-1371

[8] Ramirez JA(2019)Broad-spectrum antibiotic use and poor outcomes in community-onset pneumonia: a cohort study Eur Respir J 54 1900057-944

[9] Wiemken TL(2015)Hospital resource utilization and patient outcomes associated with respiratory viral testing in hospitalized patients Emerg Infect Dis 21 1366-1434

[10] Peyrani P(2017)Multiplex respiratory virus testing for antimicrobial stewardship: a prospective assessment of antimicrobial use and clinical outcomes among hospitalized adults J Infect Dis 216 936-825